We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

DecImmune Therapeutics Secures $2.25 Million in Development Funding

News   Feb 27, 2013

 
DecImmune Therapeutics Secures $2.25 Million in Development Funding
 
 
 

RELATED ARTICLES

Ebola Vaccine Could Stretch Farther

News

A new study has identified that a single dose of a highly diluted Ebola vaccine still fully protected against disease in a monkey model.

READ MORE

Creatine Fuels T Cells’ Fight Against Cancer

News

Creatine serves as a molecular battery for immune cells by storing and distributing energy to fuel their fight against cancer, according to a new study.

READ MORE

Dementia Associated With Altered Immune System

News

Recent research has revealed increased inflammatory activity in some patients with frontotemporal dementia.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE